Elanco (NYSE: ELAN) CEO receives grant of deferred stock units as pay

(Neutral)

Form Type

Rhea-AI Filing Summary

Simmons Jeffrey N reported acquisition or exercise transactions in this Form 4 filing.

Elanco Animal Health President and CEO Jeffrey N. Simmons received a grant of 125.5855 deferred stock units on May 1, 2026. These units are tied to the company’s common stock at a reference price of $22.51 per unit and are part of his compensation, not an open-market trade. Following this award, his reported deferred stock unit balance is 24,164.1158 units. Each deferred stock unit represents the right to receive one share of Elanco common stock or the cash equivalent, settling after termination of employment or in a specified future year under the company’s Executive Deferral and Stock Match Plan.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Simmons Jeffrey N

Role PRESIDENT, CEO AND DIRECTOR

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units	125.5855	$22.51	$3K

Holdings After Transaction: Deferred Stock Units — 24,164.1158 shares (Direct)

Footnotes (2)

F1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
F2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

Key Figures

Deferred stock units granted: 125.5855 units Reference price per unit: $22.51 per unit Deferred stock units after grant: 24,164.1158 units +2 more

5 metrics

Deferred stock units granted 125.5855 units Grant to CEO on May 1, 2026

Reference price per unit $22.51 per unit Value used for the May 1, 2026 grant

Deferred stock units after grant 24,164.1158 units CEO’s reported deferred unit balance following transaction

Transaction code A (Grant, award, or other acquisition) Form 4 classification of the deferred stock unit grant

Underlying security Common Stock Each unit represents right to one share or cash equivalent

Key Terms

Deferred Stock Units, Executive Deferral and Stock Match Plan, termination of employment

3 terms

Deferred Stock Units financial

"Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent."

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Executive Deferral and Stock Match Plan financial

"Deferred stock units settle in cash or shares ... in accordance with Executive Deferral and Stock Match Plan."

termination of employment financial

"Deferred stock units settle in cash or shares ... following termination of employment or during a specified future year..."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 05/05/2026 - 04:12 PM

FAQ

What did Elanco (ELAN) CEO Jeffrey Simmons report on this Form 4?

Elanco CEO Jeffrey N. Simmons reported receiving 125.5855 deferred stock units as compensation. The units are tied to Elanco common stock at a reference price of $22.51 and increase his deferred unit balance to 24,164.1158 units, with settlement in stock or cash later.

Are the Elanco (ELAN) deferred stock units an open-market purchase or sale?

The deferred stock units reported are a compensation-related grant, not an open-market purchase or sale. They are classified as an acquisition under code "A" and represent deferred equity awarded to the CEO, settling after employment ends or in a designated future year.

How many deferred stock units in Elanco (ELAN) does the CEO hold after this grant?

After the May 1, 2026 grant, Jeffrey N. Simmons holds 24,164.1158 deferred stock units. Each unit represents a right to receive either one share of Elanco common stock or the cash equivalent, payable after termination of employment or in a specified future year.

When will the Elanco (ELAN) deferred stock units granted to the CEO be settled?

The deferred stock units will settle in cash or Elanco common shares following termination of employment or during a specified future year. Settlement timing follows the company’s Executive Deferral and Stock Match Plan, which governs how and when these deferred awards are paid.

What does each Elanco (ELAN) deferred stock unit represent for the CEO?

Each deferred stock unit represents the right to receive one share of Elanco common stock or its cash equivalent. This structure lets the CEO defer part of his compensation into equity-linked units, which are paid out after employment ends or at a preselected future date.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Simmons Jeffrey N

(Last)

(First)

(Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS

INDIANA

46221

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	PRESIDENT, CEO AND DIRECTOR

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Deferred Stock Units	⁽¹⁾	05/01/2026		A		125.5855		⁽²⁾	⁽²⁾	Common Stock	125.5855	$22.51	24,164.1158	D

Explanation of Responses:

1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.

2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

	/s/ Amy C. Seidel, as Attorney-in-Fact for Jeffrey N. Simmons	05/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR